Published in J Am Geriatr Soc on September 01, 2005
Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3. Cell Mol Life Sci (2010) 1.25
Transcriptional analysis of histone deacetylase family members reveal similarities between differentiating and aging spermatogonial stem cells. Stem Cell Rev (2013) 0.80
Human adult stem cells as the target cells for the initiation of carcinogenesis and for the generation of "cancer stem cells". Int J Stem Cells (2008) 0.80
An avian model for the reversal of neurobehavioral teratogenicity with neural stem cells. Neurotoxicol Teratol (2010) 0.79
A mechanism-based complementary screening approach for the amelioration and reversal of neurobehavioral teratogenicity. Neurotoxicol Teratol (2009) 0.76
Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat Biotechnol (2012) 7.37
Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell (2011) 6.82
Regulatory networks define phenotypic classes of human stem cell lines. Nature (2008) 4.98
A bioinformatic assay for pluripotency in human cells. Nat Methods (2011) 3.66
Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell (2011) 3.32
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A (2009) 2.96
Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell (2012) 2.94
Human embryonic stem cells have a unique epigenetic signature. Genome Res (2006) 2.89
Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Stem Cells (2008) 2.52
A call for standardized naming and reporting of human ESC and iPSC lines. Cell Stem Cell (2011) 2.48
Friedreich's ataxia induced pluripotent stem cells model intergenerational GAA⋅TTC triplet repeat instability. Cell Stem Cell (2010) 2.02
Gene therapy: can neural stem cells deliver? Nat Rev Neurosci (2006) 1.95
A call to standardize teratoma assays used to define human pluripotent cell lines. Cell Stem Cell (2010) 1.93
Conversion of human fibroblasts to angioblast-like progenitor cells. Nat Methods (2012) 1.91
Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice. J Neurosci (2003) 1.76
Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One (2011) 1.75
Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. BMC Dev Biol (2006) 1.58
Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells (2005) 1.58
Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell (2008) 1.57
Induced pluripotent stem cells from highly endangered species. Nat Methods (2011) 1.24
The functions of microRNAs in pluripotency and reprogramming. Nat Cell Biol (2012) 1.23
Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis. Cell Res (2011) 1.17
Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells. Cryobiology (2006) 1.15
Differentiation of neural lineage cells from human pluripotent stem cells. Methods (2008) 1.13
Genomic instability in pluripotent stem cells: implications for clinical applications. J Biol Chem (2013) 1.13
DNA methylation in embryonic stem cells. J Cell Biochem (2010) 1.11
Epigenetic therapy for Friedreich ataxia. Ann Neurol (2014) 1.11
Highly parallel genome-wide expression analysis of single mammalian cells. PLoS One (2012) 1.10
Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy. PLoS One (2011) 1.10
NTera2: a model system to study dopaminergic differentiation of human embryonic stem cells. Stem Cells Dev (2005) 1.08
BMP4-directed trophoblast differentiation of human embryonic stem cells is mediated through a ΔNp63+ cytotrophoblast stem cell state. Development (2013) 1.07
Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models. Stem Cell Res Ther (2014) 1.05
Isolation of human embryonic stem cell-derived teratomas for the assessment of pluripotency. Curr Protoc Stem Cell Biol (2007) 1.04
Restricted ethnic diversity in human embryonic stem cell lines. Nat Methods (2010) 1.02
Transcriptome coexpression map of human embryonic stem cells. BMC Genomics (2006) 1.01
Beyond fraud--stem-cell research continues. N Engl J Med (2006) 1.00
Preparation of autogenic human feeder cells for growth of human embryonic stem cells. Curr Protoc Stem Cell Biol (2008) 0.98
Chromatin insulator elements block transgene silencing in engineered human embryonic stem cell lines at a defined chromosome 13 locus. Stem Cells Dev (2011) 0.92
Equivalence of conventionally-derived and parthenote-derived human embryonic stem cells. PLoS One (2011) 0.92
Matched miRNA and mRNA signatures from an hESC-based in vitro model of pancreatic differentiation reveal novel regulatory interactions. J Cell Sci (2013) 0.92
The ACTCellerate initiative: large-scale combinatorial cloning of novel human embryonic stem cell derivatives. Regen Med (2008) 0.91
Complexity of inflammatory responses in endothelial cells and vascular smooth muscle cells determined by microarray analysis. Ann N Y Acad Sci (2002) 0.89
Adhesive interactions between human neural stem cells and inflamed human vascular endothelium are mediated by integrins. Stem Cells (2006) 0.88
Evidence that gene activation and silencing during stem cell differentiation requires a transcriptionally paused intermediate state. PLoS One (2011) 0.85
Propagation of human embryonic and induced pluripotent stem cells in an indirect co-culture system. Biochem Biophys Res Commun (2010) 0.83
A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells. Neuro Oncol (2010) 0.80
Melanocytes derived from transgene-free human induced pluripotent stem cells. J Invest Dermatol (2013) 0.80
Equally potent? Does cellular reprogramming justify the abandonment of human embryonic stem cells? EMBO Rep (2012) 0.79
Teratoma generation in the testis capsule. J Vis Exp (2011) 0.77
Intraspinal transplantation of mouse and human neural precursor cells. Curr Protoc Stem Cell Biol (2013) 0.77
The 'sweet' spot of cellular pluripotency: protein glycosylation in human pluripotent stem cells and its applications in regenerative medicine. Expert Opin Biol Ther (2015) 0.76
A modest proposal in response to Rhodes and Schiano. Am J Bioeth (2010) 0.75
Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies. Expert Rev Neurother (2014) 0.75
Ethnically diverse pluripotent stem cells for drug development. Trends Mol Med (2012) 0.75
Growth of an industry: how U.S. scientists and clinicians have enabled stem cell tourism. Am J Bioeth (2010) 0.75
Stem cell reprogramming: basic implications and future perspective for movement disorders. Mov Disord (2014) 0.75